Skip to Main Content

Author Details

Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
2004
246
46
PMIDPaper TitleJournal TitlePublished Year
37877215Origin and outcome of metastatic tumours to the testes: a nationwide study.BJU Int2024
35129488Trends in Distal Esophageal and Gastroesophageal Junction Cancer Care: The Dutch Nationwide Ivory Study.Ann Surg2023
37589234Delayed Versus Immediate Start of Chemotherapy in Asymptomatic Patients With Advanced Cancer: A Meta-Analysis.Oncologist2023
37001837The association between wearable device metrics and clinical outcomes in oncology: A systematic review with evidence synthesis and meta-analysis.Crit Rev Oncol Hematol2023
37030113Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries.ESMO Open2023
36848749Treatment patterns and survival in older adults with unresected nonmetastatic biliary tract cancers.J Geriatr Oncol2023
34086597Linked Colour imaging for the detection of polyps in patients with Lynch syndrome: a multicentre, parallel randomised controlled trial.Gut2022
35413826Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.BMC Cancer2022
35880759Recurrent Disease After Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study.Ann Surg2022
33610543Prognosis of Interval Distant Metastases After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.Ann Thorac Surg2022
35047330Real-time diagnostic accuracy of blue light imaging, linked color imaging and white-light endoscopy for colorectal polyp characterization.Endosc Int Open2022
35314096A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases.Eur J Surg Oncol2022
35039626Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma.Br J Cancer2022
34635432The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer: a propensity score matched analysis.HPB (Oxford)2022
33418527Cachexia and Dietetic Interventions in Patients With Esophagogastric Cancer: A Multicenter Cohort Study.J Natl Compr Canc Netw2021
33760073Conversion of a colorectal cancer guideline into clinical decision trees with assessment of validity.Int J Qual Health Care2021
33837791Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study.J Natl Cancer Inst2021
33636694SOURCE: Prediction Models for Overall Survival in Patients With Metastatic and Potentially Curable Esophageal and Gastric Cancer.J Natl Compr Canc Netw2021
34530127Long-Term Quality of Life after Minimally Invasive vs Open Distal Pancreatectomy in the LEOPARD Randomized Trial.J Am Coll Surg2021
34251543Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.Gastric Cancer2021
34293719SOURCE-PANC: A Prediction Model for Patients With Metastatic Pancreatic Ductal Adenocarcinoma Based on Nationwide Population-Based Data.J Natl Compr Canc Netw2021
34117567The association between wearable activity monitor metrics and performance status in oncology: a systematic review.Support Care Cancer2021
31251346Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis.J Natl Cancer Inst2020
31813320Gastro-oesophageal junction: to FLOT or to CROSS?Acta Oncol2020
31809243Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.J Clin Oncol2020
31927675Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study.Gastric Cancer2020
32048563Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study.Acta Oncol2020
31919404Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial.Br J Cancer2020
33107709Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study.Cancer Med2020
33189037Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.Eur J Cancer2020
33075684Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review.Cancer Treat Rev2020
32690011Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.Health Qual Life Outcomes2020
32727761Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.Anticancer Res2020
32980749Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.Eur J Cancer2020
32244310External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer Patients.Cancers (Basel)2020
32464483Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.Crit Rev Oncol Hematol2020
32540465Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.Biochim Biophys Acta Rev Cancer2020
32458162Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN).Eur J Health Econ2020
31472016From presentation to paper: Gender disparities in oncological research.Int J Cancer2020
31340065Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study.Int J Cancer2020
30641964The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysis.Cancers (Basel)2019
31207904Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).Cancers (Basel)2019
31403035COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis.Front Oncol2019
31255992Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis.Crit Rev Oncol Hematol2019
31508373The Use of (Network) Meta-Analysis in Clinical Oncology.Front Oncol2019
31017020TOXview: a novel graphical presentation of cancer treatment toxicity profiles.Acta Oncol2019
31013858Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.Cancers (Basel)2019
31090160Ecological momentary assessments among patients with cancer: A scoping review.Eur J Cancer Care (Engl)2019
30764578SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer.Cancers (Basel)2019
30852117Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer.Patient Educ Couns2019
  • 1 - 50 of 246

Recommended Authors

Imperial College London
Career Start Year 2016
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 0
Western University
Career Start Year 2011
Number of shared co-authors 0
University of California San Diego, Veterans Affairs San Diego Healthcare System
Career Start Year 2009
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
university of california los angeles School of Medicine
Career Start Year 2008
Number of shared co-authors 5
Evidence Foundation
Career Start Year 2008
Number of shared co-authors 2
Schulich school of Medicine, Western University.
Career Start Year 2007
Number of shared co-authors 1
University of California San Diego
Career Start Year 2007
Number of shared co-authors 4
Northeastern University
Career Start Year 2006
Number of shared co-authors 0
Western University
Career Start Year 2006
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
university of california los angeles School of Medicine
Career Start Year 2004
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 0
Columbia University
Career Start Year 2002
Number of shared co-authors 0
University of Alberta, Canada Cross Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Royal Brisbane and Women's Hospital
Career Start Year 2000
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Lovisenberg Diaconal Hospital
Career Start Year 1998
Number of shared co-authors 0
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1994
Number of shared co-authors 2
University Health Network
Career Start Year 1994
Number of shared co-authors 1
University College London (UCL)
Career Start Year 1990
Number of shared co-authors 1
University of California
Career Start Year 1990
Number of shared co-authors 4
The University of Michigan ann arbor
Career Start Year 1990
Number of shared co-authors 0
Section of Health Services Research, Baylor College of Medicine
Career Start Year 1989
Number of shared co-authors 0
Farncombe Family Digestive Health Research Institute, McMaster University
Career Start Year 1989
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1983
Number of shared co-authors 0

Collaborators

Cancer Center Amsterdam
Co-authored papers 54
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Co-authored papers 10
Co-authored papers 4
University Medical Center Utrecht
Co-authored papers 3
Uppsala University
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Antwerp University Hospital
Co-authored papers 3
The Netherlands Cancer Institute
Co-authored papers 3
Co-authored papers 3
Oncode Institute
Co-authored papers 2
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
University Medical Center Utrecht
Co-authored papers 2
Co-authored papers 2
David Geffen School of Medicine at University of California Los Angeles
Co-authored papers 2
Co-authored papers 2
Cancer Health Services Research, The University of Melbourne
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Albert Schweitzer Hospital
Co-authored papers 2
Co-authored papers 1
Technical Medical Centre, University of Twente
Co-authored papers 1
Co-authored papers 1
Leiden University Medical Center
Co-authored papers 1
F. Widjaja Inflammatory Bowel Disease Institute
Co-authored papers 1
Oncode Institute
Co-authored papers 1